June 2001
Supplement
HBS Case Collection

Merck & Company: Evaluating a Drug Licensing Opportunity

By: Richard S. Ruback

Format:Multimedia
| Pages:0

Abstract

Spreadsheet to (9-201-023). Download only.

Citation

Ruback, Richard S. "Merck & Company: Evaluating a Drug Licensing Opportunity." Harvard Business School Spreadsheet Supplement 201-707, June 2001.

Purchase

About The Author

Richard S. Ruback

Finance

More Publications

More from the Author

- June 2023
- Faculty Research
Rent Control in Boston, Again?

By: Robin Greenwood, Richard S. Ruback, Robert Ialenti and Tom Quinn
- May 2023
- Faculty Research
Natural Gas in New England

By: Robin Greenwood, Richard S. Ruback and Gil Highet
- May 2023
- Faculty Research
Legacy Partners

By: Royce Yudkoff and Richard S. Ruback